TEVA Epirubicin is an epirubicin hydrochloride injection at 2 mg/mL, supplied as 50 mg/25 mL in a single 25 mL vial. Classified as an immunosuppressant, this solution is intended for intravenous administration. It carries DIN 02324091 and requires a prescription in Canada and Quebec. Approved for use.